Information Provided By: 
Fly News Breaks for March 21, 2017
SPLK
Mar 21, 2017 | 07:22 EDT
UBS analyst Fatima Boolani said Splunk investors' main concern is the stock's high multiple, but she believes the company can grow into it. She cited a runway for new customer growth, its compelling role in monetizing secular data growth, its flexible platform that could support upward estimate revisions, and increasing large deal metrics. Boolani reiterated her Buy rating and raised her price target to $72 from $70 on Splunk shares.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
